Furthermore, recent studies highlight that TGF-β activity within the glioma microenvironment influences not only tumor cells but also immune and stromal components, positioning TGF-β as a central modulator of tumor plasticity [14]. The gene discussed is TGFB1; the disease is central nervous system cancer.